Open access · OA
via OpenAlex
Melatonin as an antioxidant: under promises but over delivers
Rüssel J. Reiter, Juan C. Mayo, Dun‐Xian Tan, Rosa M. Sáinz, Moisés Alejandro Alatorre-Jiménez, Lilan Qin
Journal of Pineal Research · 2016 · ▲ 1,686 citations
Abstract
Melatonin is uncommonly effective in reducing oxidative stress under a remarkably large number of circumstances. It achieves this action via a variety of means: direct detoxification of reactive oxygen and reactive nitrogen species and indirectly by stimulating antioxidant enzymes while suppressing the activity of pro-oxidant enzymes. In addition to these well-described actions, melatonin also reportedly chelates transition metals, which are involved in the Fenton/Haber-Weiss reactions; in doing so, melatonin reduces the formation of the devastatingly toxic hydroxyl radical resulting in the reduction of oxidative stress. Melatonin's ubiquitous but unequal intracellular distribution, including its high concentrations in mitochondria, likely aid in its capacity to resist oxidative stress and cellular apoptosis. There is credible evidence to suggest that melatonin should be classified as a mitochondria-targeted antioxidant. Melatonin's capacity to prevent oxidative damage and the associated physiological debilitation is well documented in numerous experimental ischemia/reperfusion (hypoxia/reoxygenation) studies especially in the brain (stroke) and in the heart (heart attack). Melatonin, via its antiradical mechanisms, also reduces the toxicity of noxious prescription drugs and of methamphetamine, a drug of abuse. Experimental findings also indicate that melatonin renders treatment-resistant cancers sensitive to various therapeutic agents and may be useful, due to its multiple antioxidant actions, in especially delaying and perhaps treating a variety of age-related diseases and dehumanizing conditions. Melatonin has been effectively used to combat oxidative stress, inflammation and cellular apoptosis and to restore tissue function in a number of human trials; its efficacy supports its more extensive use in a wider variety of human studies. The uncommonly high-safety profile of melatonin also bolsters this conclusion. It is the current feeling of the authors that, in view of the widely diverse beneficial functions that have been reported for melatonin, these may be merely epiphenomena of the more fundamental, yet-to-be identified basic action(s) of this ancient molecule.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/jpi.12360
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Reiter, R.J., Mayo, J.C., Tan, D., Sáinz, R.M., Alatorre-Jiménez, M.A., & Qin, L. (2016). Melatonin as an antioxidant: under promises but over delivers. <em>Journal of Pineal Research</em>. https://doi.org/10.1111/jpi.12360
Vancouver
Reiter RJ, Mayo JC, Tan D, Sáinz RM, Alatorre-Jiménez MA, Qin L. Melatonin as an antioxidant: under promises but over delivers. Journal of Pineal Research. 2016. doi:10.1111/jpi.12360.
BibTeX
@article{rssel2016Melato,
title = {Melatonin as an antioxidant: under promises but over delivers},
author = {Rüssel J. Reiter and Juan C. Mayo and Dun‐Xian Tan and Rosa M. Sáinz and Moisés Alejandro Alatorre-Jiménez and Lilan Qin},
journal = {Journal of Pineal Research},
year = {2016},
doi = {10.1111/jpi.12360},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Pineal Research 2015
Open access · OA
Melatonin: an ancient molecule that makes oxygen metabolically tolerable
Free Radical Research 2013
Citation only
DhHP-6 extends lifespan of<i>Caenorhabditis elegans</i>by enhancing nuclear translocation and transcriptional activity of DAF-16
World Journal of Gastroenterology 2014
Open access · OA
Oxidative stress as a crucial factor in liver diseases
Biogerontology 2025
Citation only
Synergistic effects of 3-O-methylquercetin and polyphenols on longevity, healthspan, and neuroprotection via FOXO/Nrf2.
The EMBO Journal 2016
Open access · CC-BY
The effects of proteasomal inhibition on synaptic proteostasis
Journal of Pharmacy and Pharmacology 2013
Open access · OA